The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Gelofusine 40mg/ml Solution for Infusion

40 milligram(s)/millilitre Solution for infusion

B. Braun Melsungen AGPA0736/011/001

Main Information

Trade NameGelofusine 40mg/ml Solution for Infusion
Active SubstancesSuccinylated gelatine (= modified fluid gelatine)
Sodium chloride
Sodium hydroxide
Strength40 milligram(s)/millilitre
Dosage FormSolution for infusion
Licence HolderB. Braun Melsungen AG
Licence NumberPA0736/011/001

Group Information

ATC CodeB05AA Blood substitutes and plasma protein fractions
B05AA06 gelatin agents


Licence Issued03/03/2000
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back